Skip to content
Insider tapeFilings through Fri, Oct 2

Jonathan Biller

General Counsel at Vertex Pharmaceuticals Inc / Ma (VRTX)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $3.8M

Reported trades

Filed Stock Type Shares Price Value Since
Feb 26SEC VRTXVertex Pharmaceuticals Inc / Ma Sell Plan 945 $486.35 $460K +3.5%
Feb 19SEC VRTXVertex Pharmaceuticals Inc / Ma Sell Plan 2,476 $489.46 $1.2M +2.9%
Feb 19SEC VRTXVertex Pharmaceuticals Inc / Ma Sell Plan 1,244 $473.68 $589K +6.3%
Feb 18SEC VRTXVertex Pharmaceuticals Inc / Ma Sell Plan 988 $499.00 $493K +0.9%
Feb 12SEC VRTXVertex Pharmaceuticals Inc / Ma Sell Plan 1,925 $460.43 $886K +9.4%
Dec 5SEC VRTXVertex Pharmaceuticals Inc / Ma Sell Plan 347 $449.00 $156K +12.1%
  • Sell

    General Counsel Jonathan Biller sold $460K of VRTX at $486.35 — pre-scheduled 10b5-1 plan sale.

  • Sell

    General Counsel Jonathan Biller sold $1.2M of VRTX at $489.46 — pre-scheduled 10b5-1 plan sale.

  • Sell

    General Counsel Jonathan Biller sold $589K of VRTX at $473.68 — pre-scheduled 10b5-1 plan sale.

  • Sell

    General Counsel Jonathan Biller sold $493K of VRTX at $499.00 — pre-scheduled 10b5-1 plan sale.

  • Sell

    General Counsel Jonathan Biller sold $886K of VRTX at $460.43 — pre-scheduled 10b5-1 plan sale.

  • Sell

    General Counsel Jonathan Biller sold $156K of VRTX at $449.00 — pre-scheduled 10b5-1 plan sale.